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 Abstract    
Background: Lymph node (LN) micrometastatic disease has come to prominence since ultrastaging was shown 
to improve the quality of LN procedures in epithelial cancers. The aim of the study was to evaluate the feasibility 
and diagnostic usefulness of detecting micrometastases in sentinel (SLN) and non-sentinel LNs (nSLN) in cervical 
cancer.
Material and methods: Twelve consecutive patients with cervical cancer stages IA to IIA, classiﬁed according to 
the Union for International Cancer Control (UICC) and divided into two groups: A (7) and B (5), with and without SLN 
procedure with methylene blue dye, who underwent radical hysterectomy and lymph nodes removal, were recruited 
for the study. All LNs were evaluated in hematoxylin-eosin (HE) staining and immunohistochemically (IHC) in ultra-
staging with anti-cytokeratin AE1/AE3 antibodies. A detailed analysis was performed with regard to the technical 
and histopathological aspects of the procedure.
Results: More LNs could be extracted and studied in group A as compared to group B (210 vs. 70, mean 30 vs. 
14, respectively, p <0.0005). A total of 13 SLNs were extracted, and the identiﬁcation rate was 71% (5/7 in group 
A). One micrometastatic LN was found in each of the groups (16% cases), but the preliminary classiﬁcation of the 
advancement stage was changed only in 1 case from the labeled nodes group (group A - from pN0 with HE to pN1 
with IHC).
Conclusions: Presence or absence of metastases in SLN(s) should not be suﬃcient amount of information for a 
surgeon or an oncologist, who ought to have data about all of the removed lymph nodes (sent to ultrastaging). In 
order for the surgery to be performed properly, it is vital to ensure that SLNs were removed. Assessment of the N 
status ought to be taken into consideration in the classiﬁcation according to the International Federation of Gyne-
cology and Obstetrics (FIGO).
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Introduction
Micrometastases mic1s are tumor deSosits ranJinJ Irom 
at least 2cell clusters uS to 2mm in diameter nodules in a 
lymSK node >1@ Micrometastases KaYe been Iound to KaYe tKe 
same SroJnostic siJni¿cance as macrometastases in cerYical can-
cer >2@ 7o tKe best oI our knowledJe, no study so Iar Kas Iocused 
on tKe Ieasibility and clinical imSact oI detectinJ mic1s in all 
lymSK nodes ,n tKe larJest study oI &ibula et al, tKe SroJnostic 
role oI non-sentinel lymSK nodes nSL1s was not sSeci¿ed >2@ 
,ntroduction oI ultrastaJinJ into SatKoloJical staJinJ Kas brouJKt 
broader sSectrum oI lymSK node assessment in some cancers oI 
tKe eSitKelial oriJin >-@ 
+oweYer, it does not seem to be time-eIIectiYe in tKe intra-
surJical conte[t >@ 7Kis tecKniTue Kas an increased sensitiYity 
but reTuires a sSecial metKod oI SL1 labelinJ witK tKe use oI ra-
dioisotoSe, andor by SroYidinJ a dye absorbed by lymSK Yessels 
and relatinJ nodes 7Ke time itselI is a stronJ limitation oI assess-
inJ L1s in ultrastaJinJ settinJ because tKis metKod reTuires one 
or two workinJ days oI a sinJle SatKoloJist accordinJ to our own 
e[Serience, tKus beinJ relatiYely time-consuminJ 
,n recent years, SL1 Kas acKieYed a JrowinJ amount oI Io-
cus and attention +oweYer, in tKe conte[t oI skiS or occult me-
tastases wKicK miJKt occur in uS to  oI cerYical cancer cases 
staJe ,b2-,,b accordinJ to tKe ,nternational )ederation oI *y-
necoloJy and 2bstetrics, ),*2 >-@, unknown SroSortion oI 
SositiYe mic1s Ser staJe, unclear siJni¿cance oI mic1s in tKe 
nSL1s, and une[Sected lymSK Yessel basins in eacK Sarticular 
Satient, miJKt constitute an indication to remoYe all lymSK nodes 
7Kis Srocedure may be SerIormed in order to IurtKer e[tend tKe 
¿eld oI radiotKeraSy Ior better cancer control >1@ 7Ke Tuestion 
wKetKer ultrastaJinJ is to be used in tKe assessment oI all lymSK 
nodes remains a source oI mucK debate >1-12@ 2ur study was 
desiJned to enKance our understandinJ about tKe sSreadinJ oI 
cancer cells Irom tKe Srimary oSerable cerYical cancer +oweYer, 
SL1 detection and nSL1 ultrastaJinJ miJKt also maintain tKeir 
own imSortance in adYanced staJes oI tKe disease >12@
Material and methods
7welYe consecutiYe Satients witK Srimary cerYical cancer, 
con¿rmed by KistoloJic e[amination and clinically eliJible Ior 
radical Kysterectomy, were eYaluated in tKe study $ll Satients 
underwent a radical Kysterectomy 3iYer-5utledJe ,,-,,, witK 
diIIerent e[tent oI lymSKadenectomy and all but two Kad bilateral 
ooSKorectomy 
,n JrouS $,  ml oI metKylene blue was injected into tKe 
cerYi[ submucosa to , ,  and 12 Kours oI tKe YaJinal Sortion 
outside tKe tumor beIore eacK surJical Srocedure $ll but one 
case were sTuamous cell tySe KistoloJy 7Ke sSecimens were rou-
tinely assessed witK tKe e[ceStion oI tKe lymSK nodes tKat were 
subjected to ultrastaJinJ %rieÀy, tKe lymSK nodes were cut into 
2-mm slices (acK oI tKese slices was diYided into two blocks 
and ¿nally cut at 1 m in order to eYaluate tKem KistoloJically 
Sections were stained witK Kemato[ylin-eosin +( and ultrast-
aJed witK anti-cytokeratin $(1$( antibodies D$.2 1ortK 
$merica, ,nc 2 9ia 5eal, &arSinteria, &$ 1, 8S$ 
7Ke details oI tKe Srocedure Kad been SreYiously described 
in anotKer study >@ Statistical analysis was SerIormed witK Sta-
tistica Y 1 SackaJe StatsoIt ,nc, 3oland 
 Key words: micrometastases / ultrastaging system / non-sentinel lymph nodes / 
         /cervical cancer / cancer staging / 
 Streszczenie
Cel pracy: Mikroprzerzutowa choroba węzłowa zyskała na znaczeniu odkąd wykazano, że ultrastaging poprawia 
jakość procedur operacyjnych z usuwaniem węzłów chłonnych w nowotworach nabłonkowych. Celem pracy była 
ocena możliwości jak i przydatności diagnostycznej wykrywania mikroprzerzutów zarówno w węzłach wartowni-
czych (SLN) jak i pozawartowniczych (nSLN ) w raku szyjki macicy.
Materiał i metody: 12 kolejnych pacjentek z rakiem szyjki macicy sklasyﬁkowanych wg Unii dla Międzynarodowej 
Kontroli nad Rakiem (UICC) w stopniach od IA do IIA w dwóch grupach A (7) i B (5) odpowiednio z i bez procedury 
SLN z użyciem błękitu metylenowego poddano radykalnej histerektomii i limfadenktomii. Wszystkie węzły chłonne 
oceniono w barwieniu hematoksylina – eozyna (HE ) i immunohistochemiczne (IHC ) w ultrastagingu z użyciem 
przeciwciał przeciwko cytokeratynom AE1/AE3. Szczegółową analizę wykonano w odniesieniu do aspektów tech-
nicznych i histopatologicznych procedury.
Wyniki: Więcej węzłów chłonnych można było usunąć i zbadać w grupie A niż w grupie B (210 vs 70, średnio 30 
vs 14, p <0,0005). Wykryto 13 SLN, a poziom identyﬁkacji wyniósł 71% (5/7 w grupie A). Po jednym węźle chłon-
nym z mikroprzerzutami znaleziono w obu grupach (16% przypadków), ale wstępna klasyﬁkacja nowotworu została 
zmieniona tylko w jednym przypadku w grupie z oznakowywanymi węzłami (grupa A – z pN0 z HE do pN1 w IHC).
Wnioski: Obecność lub brak przerzutów do SLN nie powinna być wystarczająca dla chirurga i onkologa, którzy po-
winni mieć informację o wszystkich usuniętych węzłach chłonnych (przesłanych do ultrastagingu). Istotnym warun-
kiem przeprowadzenia prawidłowej operacji węzłowej jest upewnienie się, że materiał pooperacyjny zawiera węzły 
wartownicze. Ocenianie stanu węzłów chłonnych powinno być brane pod uwagę do oceny wg klasyﬁkacji FIGO.
 Słowa kluczowe: mikroprzerzuty / ultrastaging / pozaZartoZnicze ZĊzáy cháonne / 
      / rak szyjki macicy / stopniowanie zaawansowania raka /
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7Ke study was aSSroYed by tKe local ,ndeSendent %ioetKical 
&ommission oI Medical 8niYersity oI *dansk $ written inIormed 
consent was obtained Irom all study SarticiSants 
Results
2ut oI 12 Satients,  JrouS $ underwent tKe SL1 Sroce-
dure, and  JrouS % were not subjected to tKis Srocedure 7able 
1 Mean aJe was 1 and  years in JrouSs $ and %, resSectiYely 
,n case oI 2 Satients Irom JrouS $ ± 1 witK staJe S71a12mm
1M[ and 1 witK c71b1S12M[ ± we Iailed to iden-
tiIy SL1s 7Ke total number oI lymSK nodes was 2 JrouS $ 
21, mean  nodesSatient, ranJe 1- JrouS % , mean 1 
nodesSatient, ranJe ±2, S, two-sided t-Student test 
,n JrouS $, 2 2 out oI  Satients Kad no labeled lymSK nodes 
Iound tKrouJK dye injection %otK Satients were amonJ tKe oldest 
in tKat JrouS 2ut oI tKe  Satients, oStimal two-sided labelinJ 
oI tKe lymSK nodes basin was successIul in only 2 subjects, wKo 
Kad tKe larJest cerYical cKanJe in tKe study SoSulation S72b 
7Kirteen SL1s were identi¿ed in JrouS $ 121, 2 Metas-
tases were Iound in 2 Satients out oI 12 1, 1 in eacK JrouS 
7able 1 ,n tKe ¿rst Satient case 1, JrouS $ tKe e[oSKytic YaJi-
nal cerYical tumor was remoYed usinJ monoSolar coaJulation  
ml oI blue dye was injected into tKe macroscoSically uncKanJed 
cerYi[ outside tKe SreYious tumor, tKen radical Kysterectomy 
was SerIormed )iYe SL1s could be identi¿ed, includinJ only 
one metastatic node oI tKe leIt obturator JrouS 1mic diameter 
oI 1 mm via ultrastaJinJ Sentinel nodes were Sresent in tKe 
IollowinJ JrouSs leIt obturator 12, leIt common iliac 2 and 
riJKt obturator 1 ,n tKe second Satient case , JrouS %, witK 
c72aS112,1micM[,  inYolYed lymSK nodes were Iound, 
includinJ tKree witK macroscoSic metastases in tKe riJKt obtura-
tor node, in tKe leIt obturator node and in tKe leIt interiliac node 
1e[t to one oI tKem in tKe leIt obturator node tKe one more 
1mic became aSSarent only in ultrastaJinJ 1o blue dye was in-
jected 1o micrometastases were Iound in any oI tKe lymSK nodes 
remoYed and cKecked intraoSeratiYely
Discussion
7Ke useIulness oI SL1s labelinJ remains to be Iully eluci-
dated ,n our recent Sublication reJardinJ lymSK nodes in Jen-
eral, we KaYe discussed many Sroblems emerJinJ Irom tKe stud-
ies on lymSK nodes in cerYical cancer, and reIerred to some oI 
tKem in tKe current study ie tumor staJe, number oI e[tracted 
lymSK nodes and additional diaJnostic Sower oI labelinJ SL1s 
in comSarison to no labelinJ >1@ 7Ke basic criterion Ior tKe 
correctness oI tKe study sKould be bilateral detection oI SL1s 
$ltKouJK tKe oStimal maSSinJ oI botK sides was acKieYed only 
in 2 out oI  Satients in tKe current study, all subjects underwent 
a tKorouJK e[amination oI tKe lymSK nodes in ultrastaJinJ, wKat 
allowed to detect all Sossible metastases MarcKiolq et al, were 
amonJ tKe ¿rst to raise tKe Tuestion oI Yalidity oI lymSK node 
conceSt in cerYical cancer >1@ 7Key analyzed 2 Satients witK 
neJatiYe lymSK node metastases on routine KistoloJical e[amina-
tion and KaYe Iound 2 mic1s in SL1s and  additional mic1s in 
nSL1s 1 wKen considerinJ SL1s and 11 wKen consider-
inJ only non-sentinel lymSK nodes 7Ke IreTuency oI detection 
oI mic1s in our JrouS was also similar 1 ± 1 case Ior eacK 
JrouS witK and witKout tKe SL1 Srocedure &ertainly, a com-
SreKensiYe e[amination oI tKe lymSK nodes allows to aYoid tKe 
Sroblem oI Satient selection Ior tKe SL1 Srocedure and to omit 
tKe Tuestion oI tumor size ,ndeed, tKe border oI 2cm indicatinJ 
a tumor-related Iactor KamSers tKe detection oI SL1, but at tKe 
same time it increases tKe risk oI ¿ndinJ non-SL1 mic1s >1-
1@ 2n tKe otKer Kand, some studies were not able to demonstrate 
Table  I .  Basic characteristics of the study group.
G
ro















































TR, W-M + LDp+pa+ps
W-M + LDp (ie)
W-M + LDp













































BA + LDp+pa (ie)
W-M + LDp
W-M + LDp (ie)







Abbreviations: (sn+) – labeling of the sentinel lymph nodes; (sn-) – without labeling of the sentinel lymph nodes; TNM – staging according 
to UICC Tumor-Node-Metastasis System; LVSI – lymphovascular space invasion; ma – macrometastasis; mic – micrometastasis; X – this 
feature could not be assessed; TR – tumor resection; WM – Wertheim-Meigs surgery; LO – left obturator lymph node(s); RO – right obturator 
lymph node(s); LCI – left common iliac lymph node(s); BA – bilateral adnexectomy; LD – lymphadenectomy; LDp – pelvic lymphadenectomy; 
LDpa – paraaortic lymphadenectomy; LDps – presacral lymphadenectomy; ie – intraoperative examination *after previous conisation; **result 
based on excisional biopsy (cancer in the cervical polyp); ***adenosquamous carcinoma, grade was not given
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mic1s and draw diIIerent conclusions, desSite a small number oI 
cases but a relatiYely larJe number oI remoYed lymSK nodes >1@ 
Determination oI tKe lymSKatic Yessels sSace inYasion L9S, 
constitutes anotKer Iactor neJatiYely inÀuencinJ tKe occurrence 
oI lymSK node metastases -uretzka et al, detected tKe Sresence 
oI L9S, in 12 out oI  retrosSectiYely reYiewed Satients witK 
),*2 ,$2-,%2 lymSK node neJatiYe cerYical cancer and Iound  
L9S, cases amonJ  Satients witK mic1s 7Kere were  and 
 recurrences, resSectiYely in botK JrouSs, tKe node-neJatiYe 
and node-SositiYe >1@ ,n a study by MarcKiolq et al, reSortinJ 
on recurrent cerYical cancer witK median Iollow-uS time oI  
montKs, L9S, was Iound in  oI cases and mic1s were Iound 
in  oI cases as comSared to 2 Ior L9S, and  Ior mic1 
in tKe JrouS witKout recurrence >1@ +oweYer, it seems tKat tKere 
may be an indeSendence between L9S, and SositiYe lymSK nodes 
or tumor size as well, as was demonstrated by our inYestiJation, 
but also by a mucK larJer study oI &ibula et al >@ ,n our study, 
tKe SarticiSants, at Yarious staJes oI early cerYical cancer in a 
Yariety oI clinical situations, were subjected to tKe radical tumor 
and lymSK node surJery and comSreKensiYe lymSK nodes assess-
ment ,t reSresents a Iairly wide ranJe oI analyses as tKe new 
Satients will be introduced to tKe study
Conclusions
Small samSle size did not allow us to draw any de¿nite con-
clusions 5eJardless, it can be clearly seen tKat witKout tKe use 
oI tKe blue dye a statistically lower number oI lymSK nodes can 
be identi¿ed and e[cised, as comSared to tKe use oI tKe blue dye 
marker mean  Ys 1 ,n addition, tumor micrometastases 
were obserYed in botK JrouSs, wKicK stresses tKe imSortance oI 
lymSK nodes ultrastaJinJ, ratKer tKan IocusinJ only on labelinJ 
and cKeckinJ tKe SL1s Sentinel lymSK nodes are most common-
ly detected in tKe JrouS oI SelYic lymSK nodes corresSondinJ to 
tKe JrouS oI obturator lymSK nodes ,n addition to tKe criteria 
oI bilateral maSSinJ oI tKe SL1s, it sKould be aimed to Jet tKis 
JrouS oI lymSK nodes amonJ otKers SLSs and nSL1s 8ltrastaJ-
inJ allowed tKe detection oI additional mic1s in 2 Satients, but 
it did not cKanJe tKe S1 status in 1 case additional mic1 to  
macrometastases in case no  ,n tKe case no 1, tKe status oI 
tKe S1 Kas cKanJed into a KiJKer staJe Irom S1 witK +( to 
S11mic witK ,+&
LymSK nodes remain an imSortant issue, as it concerns an 
introduction oI node staJe diIIerentiation across ),*2 staJes into 
11-12-1 or at least 11, wKicK is not yet recoJnized like in tKe 
7umor-1ode-Metastasis system oI 8,&& 2n tKe contrary, tKe 1 
Ieature may be iJnored and ),*2 staJinJ may not include lymSK 
nodes metastases as a seSarate SroJnostic and SredictiYe Iactor 
,t seems tKat tKe Sotential aSSlicability oI lymSK node bioSsy 
sKould be taken into account beIore eacK surJery Ior better staJ-
inJ ,t seems also aSSarent tKat, based on a series oI e[Seriments, 
it is imSossible to determine tKe useIulness oI ultrastaJinJ ,t is 
tKereIore reasonable to SroSose an international trial to analyze 
cost-, time- and lonJ-term SroJnostic eIIectiYeness oI remoYal 
and ultrastaJinJ oI all tKe lymSK nodes at all staJes oI cerYical 
cancer
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